Tatiana Conrad1, Steve MacLellan2, Zahra Kassam3, Helen Mackay4, Ida Khalili5, Jenna Sykes6, Tom Purdie3, Allan Okrainec2, Jolie Ringash3. 1. Department of Radiation Oncology, Princess Margaret Cancer Centre, 610 University Avenue, 5th Floor, Toronto, ON, M5G 2M9, Canada. tatiana.conrad@rmp.uhn.on.ca. 2. Department of Surgery, University Health Network, Toronto, Canada. 3. Department of Radiation Oncology, Princess Margaret Cancer Centre, 610 University Avenue, 5th Floor, Toronto, ON, M5G 2M9, Canada. 4. Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada. 5. Department of Radiology, University Health Network, Toronto, Canada. 6. Department of Statistics, Princess Margaret Cancer Centre, Toronto, Canada.
Abstract
BACKGROUND: Since the Intergroup 0116 study was published in 2000, adjuvant postoperative chemoradiotherapy using CT-planned and 3D conformal/intensity-modulated radiotherapy has been offered routinely to fit patients with resected gastric cancer at Princess Margaret Hospital .The objective of this study was to analyze patterns of disease recurrence with respect to the radiotherapy volumes. METHODS: For the date and site (local, locoregional, or distant) of the first recurrence, medical records were reviewed for all patients treated at Princess Margaret Hospital with adjuvant chemoradiotherapy for resected gastric adenocarcinoma (January 1, 2000 to November 30, 2009). Patients whose recurrences were limited to local and/or regional sites were selected for further analysis. Available diagnostic imaging of the recurrence site was registered to the original planning radiotherapy dataset for contouring. If necessary to respect changes in anatomy, the contour was translocated on the basis of anatomic descriptors. The center of mass for each recurrence was identified as a point and its location was categorized according to the isodose encompassing it; in field (90 % or more), marginal (50-89 %), or out of field (less than 50 %). RESULTS: Of all 197 patients, 14 (7 %) had isolated locoregional failure, constituting 20 % of all 71 patients with a recurrence. Successful fusions were feasible in five cases. Of these recurrences, four were in field and one was marginal. In a further four cases, visual inspection was used, showing one in-field recurrence, one marginal recurrence, and two out-of-field recurrences. In five patients, either a useable original dataset or diagnostic imaging of the recurrence was not available. CONCLUSIONS: The rates of isolated local/locoregional tumor recurrence in this study were low. Of the small number of recurrences available for analysis, most (five of nine) were in field. Further studies involving a larger cohort of patients might allow a more meaningful analysis of trends in the recurrence site with evolving radiotherapy techniques.
BACKGROUND: Since the Intergroup 0116 study was published in 2000, adjuvant postoperative chemoradiotherapy using CT-planned and 3D conformal/intensity-modulated radiotherapy has been offered routinely to fit patients with resected gastric cancer at Princess Margaret Hospital .The objective of this study was to analyze patterns of disease recurrence with respect to the radiotherapy volumes. METHODS: For the date and site (local, locoregional, or distant) of the first recurrence, medical records were reviewed for all patients treated at Princess Margaret Hospital with adjuvant chemoradiotherapy for resected gastric adenocarcinoma (January 1, 2000 to November 30, 2009). Patients whose recurrences were limited to local and/or regional sites were selected for further analysis. Available diagnostic imaging of the recurrence site was registered to the original planning radiotherapy dataset for contouring. If necessary to respect changes in anatomy, the contour was translocated on the basis of anatomic descriptors. The center of mass for each recurrence was identified as a point and its location was categorized according to the isodose encompassing it; in field (90 % or more), marginal (50-89 %), or out of field (less than 50 %). RESULTS: Of all 197 patients, 14 (7 %) had isolated locoregional failure, constituting 20 % of all 71 patients with a recurrence. Successful fusions were feasible in five cases. Of these recurrences, four were in field and one was marginal. In a further four cases, visual inspection was used, showing one in-field recurrence, one marginal recurrence, and two out-of-field recurrences. In five patients, either a useable original dataset or diagnostic imaging of the recurrence was not available. CONCLUSIONS: The rates of isolated local/locoregional tumor recurrence in this study were low. Of the small number of recurrences available for analysis, most (five of nine) were in field. Further studies involving a larger cohort of patients might allow a more meaningful analysis of trends in the recurrence site with evolving radiotherapy techniques.
Authors: Johan L Dikken; Edwin P M Jansen; Annemieke Cats; Berdine Bakker; Henk H Hartgrink; Elma Meershoek-Klein Kranenbarg; Henk Boot; Hein Putter; Koen C M J Peeters; Cornelis J H van de Velde; Marcel Verheij Journal: J Clin Oncol Date: 2010-04-05 Impact factor: 44.544
Authors: J Ringash; S J Khaksart; A Oza; J Couture; B Japp; M Moore; L L Siu; D Hedley; C Swallow; S Wong; B Cummings; J Kim; R Wong; J Brierley Journal: Clin Oncol (R Coll Radiol) Date: 2005-04 Impact factor: 4.126
Authors: Michael D'Angelica; Mithat Gonen; Murray F Brennan; Alan D Turnbull; Manjit Bains; Martin S Karpeh Journal: Ann Surg Date: 2004-11 Impact factor: 12.969
Authors: Valerie K Reed; Sunil Krishnan; Paul F Mansfield; Priya R Bhosale; Michelle Kim; Prajnan Das; Nora A Janjan; Marc E Delclos; Andrew M Lowy; Barry W Feig; Peter W T Pisters; Jaffer A Ajani; Christopher H Crane Journal: Int J Radiat Oncol Biol Phys Date: 2007-12-31 Impact factor: 7.038
Authors: Elena Elimova; Rebecca S Slack; Hsiang-Chun Chen; Venkatram Planjery; Hironori Shiozaki; Yusuke Shimodaira; Nick Charalampakis; Quan Lin; Kazuto Harada; Roopma Wadhwa; Jeannelyn S Estrella; Dilsa Mizrak Kaya; Tara Sagebiel; Jeffrey H Lee; Brian Weston; Manoop Bhutani; Mariela Blum Murphy; Aurelio Matamoros; Bruce Minsky; Prajnan Das; Paul F Mansfield; Brian D Badgwell; Jaffer A Ajani Journal: Oncotarget Date: 2017-07-13